Subfreezing temperatures, uncertainty about travel conditions and a general reluctance to venture outdoors made many of us hunker down and put life on hold until things began to thaw. But then April comes along — and everything explodes.
How to develop a strategy to protect your business and control your legacy.
Clients may know about buy-sell agreements but not about buy-sell disability solutions.
Advisors who focus solely on caps and participation rates miss the real marketing edge.
A fictional tale about the Three Little Pigs — and their AI use cases.
Experts say it’s possible, but it’s not without risk.
For advisors, the real change isn’t technology; it’s how technology is used.
The November midterm elections will be Congress’ priority for the remainder of 2026, and observers believe that any legislation coming out of the Capitol will be seen through that electoral prism.
Escalating catastrophe losses driven by climate exposure, development patterns and inflation are testing the limits of insurance markets.
A new Department of Labor proposal could broaden the types of investments available in workplace retirement plans.
When it comes to their benefits, workers are concerned over the cost of premiums but they also want flexibility in accessing those benefits.
The news of the Corebridge/Equitable merger provided shocks through the life and annuity markets.
Getting prescription drugs to market faster is a major priority for the Food and Drug Administration, its commissioner said during the AHIP Medicare, Medicaid, Duals and Commercial Markets Forum in Washington.
Agents and brokers have a role to play in the health care system but they may be impacted by the push for affordability that has seen carriers cutting or eliminating commissions.
Stability in the Medicare market is among the priorities for the Centers for Medicare and Medicaid Services, according to the agency’s deputy administrator and the chief policy and regulatory officer.
Perhaps the last issue in the U.S. that people of all political persuasions can agree on is that prescription drug prices are too high.
Corebridge and Equitable announced an agreement to combine in an all-stock merger, valuing the combined company at approximately $22 billion.
Crushing fraud is one of the main priorities for Medicaid and the Affordable Care Act marketplace, according to the deputy administrator and director of the Center for Consumer Information and Insurance Oversight.
NAIC regulators defended the need for private meetings Tuesday as consumer advocates and industry representatives called for more transparency.
